MMP2 and lung adenocarcinoma: Previously, Nadroparin has been suggested to reduce the invasive, migratory, and adhesive ability of human lung adenocarcinoma A549 cells by down-regulating the expression of integrin β1 and β3 as well as matrix MMP2 and 9 and by restraining the actin cytoskeleton reorganization [47].